Skip to main content
SCI logo

SCI — Investor Relations & Filings

Ticker · 4119 ISIN · TW0004119003 TW Manufacturing
Open in API
Filings indexed 1,697 across all filing types
Latest filing 2023-08-11 Major Shareholding Noti…
Country TW Taiwan
Listing TW 4119

About SCI

www.sci-pharmtech.com.tw

SCI Pharmtech, Inc. specializes in the research, development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals. Established in 1987 and originally founded by the Swiss Siegfried Group, the company provides high-quality chemical solutions and custom manufacturing services to leading global pharmaceutical corporations across Europe, North America, and Japan. Its core operations encompass advanced chemical synthesis, process optimization, and large-scale production within GMP-compliant facilities. With a robust R&D infrastructure including specialized laboratories and pilot plants, the company delivers technical excellence in complex chemical processing. SCI Pharmtech maintains a strong focus on quality assurance and international regulatory compliance, positioning itself as a reliable partner for the global healthcare and life sciences sectors.

Recent filings

Filing Released Lang Actions
112年08月僑外投資持股
Major Shareholding Notification Classification · 95% confidence The document is a statistical table showing changes in shareholding by overseas and mainland China investors, including share counts before and after a capital increase due to earnings capitalization. It includes details on shareholding categories and total shares issued. The document length is short (1073 characters) and it is a factual disclosure of shareholding changes rather than a report or announcement of a meeting or financial results. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2023-08-11 Chinese
公告本公司董事會決議辦理現金增資發行新股。
Capital/Financing Update Classification · 100% confidence The document is a formal announcement from the company 4119 旭富 regarding a board resolution to conduct a cash capital increase by issuing new shares. It details the board meeting date, the source of funds, the number of shares to be issued, pricing method, allocation to employees and public, rights and obligations of the new shares, and the intended use of funds. This is a clear update on the company's financing activity, specifically a capital increase through new share issuance. The document is short (1498 characters) and is an announcement of a financing decision rather than a full financial report or detailed presentation. Therefore, it fits the category of Capital/Financing Update (CAP).
2023-08-10 Chinese
112年第2季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement with detailed financial data for the second quarter and half-year periods of the fiscal year 112 (2023). It includes revenue, costs, expenses, net income, and earnings per share figures. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is a quarterly or interim financial report. The document length is 3562 characters, which is sufficient to contain financial data, not just an announcement. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2023-08-10 Chinese
112年第2季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the period from January 1 to June 30, 2023 (the second quarter of the fiscal year 112 in the Taiwanese calendar). It includes detailed financial data such as net income before tax, depreciation, amortization, changes in working capital, and cash flows from operating, investing, and financing activities. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document length is 2158 characters, which is sufficient to contain actual financial data, not just an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2023-08-10 Chinese
112年第2季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific asset, liability, and equity line items with amounts and percentages. The presence of actual financial statements and substantive financial data for a quarterly period (112年第2季, which corresponds to the second quarter of 2023) indicates this is a comprehensive interim financial report. The document length is 4023 characters, which is sufficient to contain actual financial data rather than just an announcement. There is no indication that this is an annual report or a simple announcement. Therefore, the document is best classified as an Interim / Quarterly Report (IR).
2023-08-10 Chinese
112年第2季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial tables showing changes in equity for the first half of the year 2023 (民國112年上半年度) and the same period in the previous year. It includes line items such as common stock, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, and total equity. The presence of comprehensive financial data for a half-year period indicates this is a financial report for an interim period. The document length is 3897 characters, which is relatively short but contains substantive financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2023-08-10 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.